Wordt geladen...
The Risk Factors for the Wearing-Off Phenomenon in Parkinson's Disease
Introduction: First-line treatment of Parkinson's disease (PD) includes a dopamine analog, levodopa, administered in combination with carbidopa to increase efficacy. Wearing-off (WO) phenomenon is a frequent complication which is defined as a reoccurrence of motor and non-motor symptoms during...
Bewaard in:
| Gepubliceerd in: | Cureus |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cureus
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7599057/ https://ncbi.nlm.nih.gov/pubmed/33145134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10729 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|